Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2012-08-01 / Cancer Cell Int. 2012 Aug;12(1):35Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-04-26 / Braz. J. Med. Biol. Res. 2012 Jun;45(6):510-5Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-03-07 / Breast Cancer Res. 2012 Mar;14(2):R39HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-17 / Cancer 2012 Sep;118(17):4354-62A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-01 / J Immunother 2012 Jan;35(1):54-65Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
/in Breast Cancer, Dendritic Cells, Hypernephroma, International Publications /von 2011-10-20 / J Transl Med 2011 Oct;9:178HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-40Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-99
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution